Veracyte | VCYT - Trade Debtors


Veracyte reported $50.11M in Trade Debtors for its fiscal quarter ending in March of 2026.





Trade Debtors Change Date
Agenus USD 22.44M 1.14M Dec/2025
Agilent USD 1.52B 34M Dec/2025
Anika Therapeutics USD 29.33M 661K Dec/2025
Arrowhead Research USD 15.68M 203.19M Mar/2026
Bruker USD 542.7M 2.2M Mar/2026
Heron Therapeutics USD 89.59M 8.54M Dec/2025
Illumina USD 738M 116M Mar/2026
Intrexon USD 1.02M 559K Jun/2024
Karyopharm Therapeutics USD 26.18M 5.6M Dec/2025
Laboratory Of America USD 2.45B 189.8M Mar/2026
Ligand Pharmaceuticals USD 54.8M 6.25M Mar/2026
Myriad Genetics USD 115.3M 2.7M Dec/2025
Rigel Pharmaceuticals USD 28.9M 1.39M Jun/2024
Roche Holding CHF 11.9B 460M Dec/2025
Sangamo BioSciences USD 581K 110K Jun/2024
Siemens EUR 28.1B 1.3B Mar/2026
Sonic Healthcare AUD 1.39B 23.76M Dec/2024
Thermo Fisher Scientific USD 9.2B 304M Mar/2026
Veracyte USD 50.11M 5.45M Mar/2026
Waters USD 1.76B 930.16M Mar/2026